secwatch.observer — SEC 8-K summary
======================================

Issuer:     CRISPR Therapeutics AG (CRSP)
CIK:        0001674416
Form:       8-K
Filed at:   2025-10-15T23:59:59+00:00
Accession:  0001193125-25-240282
Event type: other
Sentiment:  neutral
Materiality: 0.75
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CRISPR Therapeutics files $600M ATM offering through Jefferies
--------------------------------------------------------------

- Filed prospectus supplement to sell up to $600M of common shares at-the-market.
- Offering uses existing shelf registration (Form S-3ASR filed Aug 5, 2024).
- Jefferies LLC acts as sole sales agent; shares sold at company's discretion.
- Legal opinion of Walder Wyss AG filed as Exhibit 5.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1674416/000119312525240282/0001193125-25-240282-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1674416/000119312525240282/crsp-20251015.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-240282

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer